NaturalShrimp, Inc. (OTCQB: SHMP), a leader in biotechnology aquaculture, has been invited to participate in The Wall Street Conference 2022 'Billionaires Row', taking place from March 7-9, 2022 at the Four Seasons Resort in Palm Beach, Florida. Chief Financial Officer William Delgado will represent the company to engage with accredited investors and wealth managers. NaturalShrimp is also sponsoring breakfast sessions during the event. The company specializes in sustainable shrimp farming using patented RAS technology, delivering fresh shrimp free from antibiotics and chemicals.
NaturalShrimp, Inc. (OTCQB: SHMP) has signed an agreement with the Jefferson County, Florida Board for a 10-acre land lease to build a 250,000 square foot inland shrimp production facility. The facility aims to meet growing demand in Florida and is expected to benefit from up to $25 million in grant funding. Additionally, NaturalShrimp is collaborating with the Water Quality Association to create a training program for aquaculture workers, enhancing workforce development in the region. This strategic move supports the company's long-term growth objectives.
NaturalShrimp, Inc. (OTCQB: SHMP) has reinforced its partnership with Gulf Seafood Inc. to supply live shrimp, extending their trial agreement through Q1 2022. The collaboration has seen successful deliveries since November 2021, utilizing GSI's unique waterless packaging. CEO Gerald Easterling highlighted the potential for increased sales and direct supply from their LaCoste facility starting February. GSI expressed optimism for a long-term arrangement following positive customer feedback during the trial period and plans for expansion into Las Vegas and Florida.
NaturalShrimp, Inc. (OTCQB: SHMP) announced the arrival of equipment to enhance shrimp production and support a second phase salmon trial. The company is installing twenty electrocoagulation units at its LaCoste, TX and Webster City, IA facilities, despite supply chain delays. Additionally, Hydrogas reactors for aquaculture have been delivered to both U.S. facilities and Norway. The salmon trial at Marineholmen RASLab in Norway starts February 1, 2022, aiming to validate the use of Hydrogas and electrocoagulation technologies for improved fish health and production.
NaturalShrimp, Inc. (OTCQB: SHMP) has announced a groundbreaking advancement from its technical team, demonstrating that their patented electrocoagulation (EC) technology can effectively reduce nitrites in recirculating aquaculture systems (RAS) without requiring a biofilter. This capability enhances their Vibrio Suppression Technology, improving water quality and production efficiency. The company aims to leverage these technologies for potential licensing opportunities, positioning itself favorably in the aquaculture market. NaturalShrimp specializes in antibiotic-free shrimp farming using innovative enclosed RAS technology.
NaturalShrimp, Inc. (OTCQB: SHMP) announced plans to expand shrimp production at its facilities in Texas and Iowa, with new facilities in Florida and Nevada. A new 80,000 sq. ft. production building in La Coste, TX will triple output. In Iowa, retrofitting of the Webster City facility is set to begin, and a joint venture aims to build a 240,000 sq. ft. facility in Florida, pending funding. Additionally, a 480,000 sq. ft. facility in Nevada is in planning. CEO Gerald Easterling indicated that these expansions are crucial to meet increasing demand for their gourmet-grade shrimp.
NaturalShrimp, Inc. (OTCQB: SHMP) has announced funding for a second freshwater salmon trial at Marineholmen RASLab in Norway. Following promising results from a previous study using Hydrogas technology, the new trial aims to validate the effectiveness of both Hydrogas and patented electrocoagulation (EC) technology. CEO Gerald Easterling stated that these advancements could significantly enhance shrimp production and open new revenue streams through technology licensing. Results from the trial are expected later in 2022.
NaturalShrimp, Inc. (OTCQB: SHMP) announced a ramp-up in live shrimp sales to Gulf Seafood Inc. (GSI), following successful deliveries in November under a trial purchase agreement for 25,000 pounds. The company cites increasing demand for smaller shrimp, enhancing profit margins due to shorter grow-out periods. A new facility in Las Vegas is planned to boost geographical reach and distribution capabilities for live shrimp. Management highlights potential gross margins for smaller shrimp being 3-4 times higher than larger varieties, presenting significant financial opportunities.
NaturalShrimp, Inc. (OTCQB: SHMP) announced the sale of a 12% Secured Promissory Note totaling $16.32 million to Streeterville Capital, LLC, aiming to expand production in Texas and Iowa. The offering, which incurred around $1.32 million in fees, will also cover a renegotiated balance of a previous $5 million debt, lowered to $4.5 million. The note matures in 24 months and carries a 12% interest rate. CEO Gerald Easterling highlighted the company's growth strategy, including an upcoming up-listing to a major exchange.
NaturalShrimp, Inc. (SHMP) announces the appointment of W. Steven Walker as General Counsel and Secretary, effective January 1, 2022. Walker, a veteran attorney with over 45 years of experience, has been affiliated with the company since 2001 and brings extensive knowledge of corporate and transactional law. CEO Gerald Easterling emphasized the need for legal counsel to manage operational issues amid the company's rapid growth and commercialization. NaturalShrimp is known for its innovative Recirculating Aquaculture System, producing fresh, antibiotic-free shrimp.